NCT04293289View on ClinicalTrials.gov

Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 19, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Malignant MelanomaAngiosarcoma
Interventions
OTHER

CICS-1 (investigational device),SPM-011(investigational drug)

Intravenous administration of SPM-011 and neutron irradiation with CICS-1.

Trial Locations (1)

104-0045

National Cancer Center Hospital, Chuo Ku

All Listed Sponsors
collaborator

Stella Pharma Corporation

INDUSTRY

lead

Cancer Intelligence Care Systems, Inc.

INDUSTRY

NCT04293289 - Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma | Biotech Hunter | Biotech Hunter